Nature Communications (Jul 2020)

The circadian phase of antenatal glucocorticoid treatment affects the risk of behavioral disorders

  • Mariana Astiz,
  • Isabel Heyde,
  • Mats Ingmar Fortmann,
  • Verena Bossung,
  • Claudia Roll,
  • Anja Stein,
  • Berthold Grüttner,
  • Wolfgang Göpel,
  • Christoph Härtel,
  • Jonas Obleser,
  • Henrik Oster

DOI
https://doi.org/10.1038/s41467-020-17429-5
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 12

Abstract

Read online

Antenatal glucocorticoid therapy is indicated for mothers at risk of preterm delivery. Here, the authors show that the circadian phase of antenatal glucocorticoid treatment affects the risk of behavioral disorders later in life in mice and in a retrospective observational study in human infants.